Summary
In order to construct plasmid of hypoxia-inducible factor-lalpha (HIF-1α), and transfect into human lung cancer cells A549, the change in sensitivity of lung cancer cells A549 to chemotherapy was observed. HIF-1α mRNA structure region was amplified by RT-PCR and inserted into plasmid pcDNA3. The expression plasmid pcDNA3/HIF-1α was transfected into A549 with Lipofec-tAMINE™2000. The expression of HIF-1α protein was detected by Western blot. After A549 cells were transfected with HIF-1α prior to addition of 5-Fu, the growth activity was measured by growth curve, apoptosis was detected by flow cytometry at 48 h, and the levels of caspase3 and MDR-1 were determined by Western blot. The results showed that the constructed expression plasmid was analyzed with restriction enzymes and gel electrophoresis. Two DNA lanes at 2.55 kb and 5.4 kb respectively were found, which were consistent with that expected. The growth rate in 5-Fu group was significantly inhibited, and the apoptosis index and caspase3 activity were increased significantly as compared with control group. After HIF-1α being transfected into A549, the activity of MDR-1 was increased and the effect of 5-Fu was weakened. In conclusion, HIF-1α can promote chemoresistance by increasing the activation of MDR1 and suppressing apoptosis during lung cancer cells A549 induced with 5-Fu.
Similar content being viewed by others
References
Dang C V, Semenza G L. Oncogenic alterations of metabolism. Trends Biochem Sci, 1999,24(2):68–72
Axelson H, Fredlund E, Ovenberger M et al. Hypoxia-induced dedifferentiation of tumor cells — a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol, 2005,16(4–5):554–563
Clottes E. Hypoxia-inducible factor 1: regulation, involvement in carcinogenesis and target for anticancer therapy. Bull Cancer, 2005,92(2):119–127
Iyer N V, Kotch L E, Agani F et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev, 1998,12(2): 149–162
Wang G L, Jiang B H, Rue E A et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A, 1995,92(12):5510–5514
Semenza G L. HIF-1 and human disease: one highly involved factor. Genes Dev, 2000,14(16):1983–1991
Teicher B A. Physiologic mechanisms of therapeutic resistance. Hematol Oncol Clin North Am, 1995,9(2):475–506
Liu J R, Chen B Q, Yang Y M et al. Effect of apoptosis on gastric adenocarcinoma cell line SGC-7901 induced by cis-9, trans-11-conjugated linoleic acid. World J Gastroenterol, 2002,8(6):999–1004
Epstein A C, Gleadle J M, McNeill L A et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell, 2001,107(1):43–54
Bruick R K, McKnight S L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 2001,294(5545):1337–1340
Gottesman M M, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem, 1993,62:385–427
Burger H, Foekens J A, Look M P et al. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin Cancer Res, 2003,9(2):827–836
van de Donk N W, Kamphuis M M, van Dijk M et al. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein. Leukemia, 2003,17(1):211–219
Author information
Authors and Affiliations
Additional information
This project was supported by a grant from the National Natural Sciences Foundation of China (No. 30400431).
Rights and permissions
About this article
Cite this article
Zhang, W., Zhang, H. Hypoxia-inducible factor-1alpha suppressing apoptosis and increasing tolerance of lung cancer cells to chemotherapy. J. Huazhong Univ. Sc. Technol. 26, 520–523 (2006). https://doi.org/10.1007/s11596-006-0508-5
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-006-0508-5